Proposed Issue of Securities — IBXOA

Imagion Biosystems Limited announces the proposed issue of 1,500,000 options expiring 28 April, 2023. Read the announcement.


Proposed Issue of Securities — IBX

Imagion Biosystems Limited announces the proposed issue of 1,000,000 ordinary fully paid securities. Read the announcement.


Upcoming Release of Shares from Escrow

Imagion Biosystems Limited (ASX: IBX) (the Company) advises in accordance with Listing Rule 3.10A, that 2,500,000 Fully Paid Ordinary Shares will be…


Quarterly Activity Report and Appendix C

Quarterly Activity Report – Period ending 30 June 2020 Q2 Highlights: Company announces plans for the Phase I first-in-human study to be undertaken in…


Proposed Issue of Securities — IBX

Imagion Biosystems Limited has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.


Proposed Issue of Securities — IBXOA

Imagion Biosystems has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.


IBX Raises $5M in Oversubscribed Placement

$5M raised in an oversubscribed placement at 4.5c per share – equivalent to 30 day VWAP, and a 33.9% premium to 60 day VWAP. Strongly supported by existing…


Appendix 2A

The application for quotation (Appendix 2A) for listed options (IBCOA) was released to the market. Read Appendix 2A.


Trading Halt

The securities of Imagion Biosystems Limited (‘IBX’) will be placed in trading halt at the request of IBX, pending it releasing an announcement regarding a…


Results of the Annual General Meeting

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), Imagion Biosystems Limited advises the results its 2019 Annual…